Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

r the Agreement with Janssen of $50 million each, totaling $200 million, including the $50 million milestone earned on April 11, 2013, which the Company expects to collect during the quarter ended June 30, 2013. The Company may earn up to an additional $625 million in development and regulatory milestone payments, however, clinical development entails risks and the Company has no assurance as to whether or when the milestone targets might be achieved.

The Agreement with Janssen includes a cost sharing arrangement for certain development activities. In general, Janssen is responsible for approximately 60% of development costs and the Company is responsible for 40% of development costs. The Agreement with Janssen also provides for a $50 million annual cap of the Company's share of development costs and pre-tax commercialization losses for each calendar year. As of March 31, 2013, the Company's total share of collaboration costs for the 2013 calendar year to date was approximately $24.9 million.

"This past quarter has been particularly successful for our company," said Bob Duggan, CEO and Chairman of the Board. "We completed the enrollment of our first Phase III trial and are well on track with our clinical programs. We also received the third Breakthrough Therapy Designation from the FDA. Last month at the American Association of Clinical Research we had 8 poster presentations and 1 oral presentation. There are 5 additional oral and 6 poster presentations with clinical and pre-clinical updates planned for the upcoming scientific conferences this summer, the American Society of Clinical Oncology, the European Hematology Association and the International Conference on Malignant Lymphoma. Last month we earned a milestone payment of $50 million from our collaboration partner Janssen, for the start of our front line study in CLL and on March 8th we concluded a successful equity offering netting us $201 million. Pharmacyclics remains resolute in it
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... SAN DIEGO , Dec. 23, 2014 ResMed ... a significant patent infringement action against Chinese medical device manufacturer ... Commission (ITC) ruled today that BMC,s masks listed below infringe ... advertising, or selling these masks in the United ... , iVolve N2 nasal mask , Willow nasal pillows ...
(Date:12/24/2014)... Dec. 23, 2014   Assurex Health, a ... to healthcare providers for behavioral health and chronic ... $30 million in equity financing from new and ... , President and Chief Executive Officer. ... development of Assurex Health,s GeneSight ® ...
(Date:12/24/2014)... 23, 2014 Tianyin Pharmaceutical Co., Inc. ... in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... announced that the Company achieved the Public Notice ... (GMP) certificate of TPI,s Qionglai Facility (QLF) from ... public notice period is a significant procedure of ...
Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
... , , WAYLAND, Mass. , ... (Nasdaq: ELOS ), announced today that the SFDA (State ... the Alex TriVantage® multi-wavelength, Q-switched laser system and the GentleMax® ... of China , including Hong Kong . The receipt ...
... , LONDON , Feb. ... world,s few companies to be recommended for ISO 17025 accreditation ... testing. The auditor recommendation was a direct result of a ... been largely responsible for the global commercialization of Hair ...
Cached Medicine Technology:Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China 2Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China 3World-Leading Alcohol Abuse Lab Status for Trimega 2
(Date:12/25/2014)... (PRWEB) December 25, 2014 Helen Harris’ ... in Woodland Hills, California after an 8 year battle ... on Christmas Eve evening in her home in Woodland ... metastatic breast cancer. , As the ... forty years, she pioneered and championed many of today's ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... risk of burns from fires and cooking accidents increases ... cautious, an expert says. "Between Thanksgiving and New ... coming in with burns," said Dr. Steven Sandoval, medical ... of Stony Brook University Hospital in New York. ... not careful, could quickly turn tragic," Sandoval said in ...
(Date:12/25/2014)... Among early stage breast cancer patients who undergo chemotherapy ... will eventually develop leukemia as a result of their ... from a review of more than 20,000 breast cancer ... that the risk for developing treatment-related leukemia, though low, ... "The frequency of bone marrow cancers such as leukemia ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
Breaking Medicine News(10 mins):Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2
... new procedure, PRELEX. , ... Westlake Village, CA (PRWEB) ... Life (West Valley Magazine), M.D. Rajesh Khanna, founder of the Khanna ... PRELEX treats the condition of presbyopia. PRELEX can help eye patients ...
... at the University of Alabama at Birmingham (UAB) Comprehensive ... from two national nonprofit groups that are partnering in ... cancer called "triple negative" breast cancer. , The grant ... the Triple Negative Breast Cancer Foundation. , The $6.4 ...
... launches version 2.0 of it,s Award Winning iTEMP(tm) ... Portal (iTEMP) allows company executives, small business owners, ... work and businesses more efficiently by offloading their ... transcription, cataloging, expense reporting and much more; to ...
... and Case Timer Solves Widespread ProblemST. LOUIS, April 10 ... U.S. and children are the fastest growing segment. The ... danger growing under those lenses. , ... like fusarium keratitis and acanthamoeba keratitis. These are nasty ...
... April 10, 2009 A protein that the heart ... developmental program and initiates migration of heart cells and ... UT Southwestern Medical Center have found. , The molecule, ... heart,s development and encourages migration of heart cells. The ...
... appear to curb compulsive acting out, study says , , ... Parkinson,s disease drugs called dopamine agonists can cause patients ... hypersexuality, says a new study. , Mayo Clinic ... doses of dopamine agonists, such as pramipexole and ropinirole, ...
Cached Medicine News:Health News:Dr. Khanna Featured on Front Cover of Valley Life Magazine 2Health News:UAB wins $6.4 million nonprofit grant to fight aggressive breast cancer 2Health News:Unleash Your Productivity and Drive Down Your Cost: Offload Tasks to a Team of Virtual Assistants 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 2Health News:70% of Contact Lens Cases are Contaminated and Nearly 1 in 4 are Never Replaced - a Serious Problem Eye Doctors Want Fixed, WatchDog Group Reports 3Health News:Molecule prompts damaged heart cells to repair themselves after a heart attack 2Health News:Parkinson's Drugs Can Trigger Unhealthy Behaviors 2
... Unicompartmental knee arthroplasty has proven to ... tibial osteotomy and total knee arthroplasty ... is a minimally invasive unicompartmental knee ... surgery. Using the latest conservative ...
... femoral option and tibial insert which provides a ... degrees of flexion to induce a smooth stable ... of flexion. Femoral component comes in a PS ... constrained tibial insert in conjunction with the femur ...
... True to its leadership role within the ... clinical experience of the industry's leading fixed-bearing ... Knee System, with the clinically proven technology ... leading rotating platform knee. ,The result is ...
... of the unicompartmental knee offers ... destruction which means quicker rehabilitation ... long term success. The implant ... and offers multiple thickness polyethylene ...
Medicine Products: